This inventor holds 1 USPTO granted patent. Top assignee: Whitehead Institute for Biomedical Research. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Brian Bierie: Innovator in Cancer Research
Introduction
Brian Bierie is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer research, particularly in targeting cancer stem cells. His innovative work has the potential to enhance the effectiveness of conventional cancer therapies.
Latest Patents
Brian Bierie holds a patent for "Methods and compositions for targeting cancer stem cells." This patent involves methods that activate the Protein Kinase A (PKA) pathway to induce cancer stem cells (CSCs) to undergo a mesenchymal to epithelial transition. The methods described in his patent are valuable as they make CSCs more susceptible to traditional cancer treatments. Additionally, the patent outlines methods for assaying PKA pathway activity to identify compounds that selectively target CSCs.
Career Highlights
Brian Bierie is affiliated with the Whitehead Institute for Biomedical Research, where he conducts his research. His work is characterized by a commitment to advancing cancer treatment methodologies and improving patient outcomes.
Collaborations
Brian collaborates with esteemed colleagues, including Diwakar Pattabiraman and Wai Leong Tam. Their combined expertise contributes to the innovative research being conducted at the Whitehead Institute.
Conclusion
Brian Bierie's contributions to cancer research through his patent and collaborative efforts highlight his role as an important innovator in the field. His work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile